Please use this identifier to cite or link to this item:
Title: Long-term valuation of oral mavacoxib in osteoarthrosic dogs using force platform analysis
Authors: Vilar Guereño, José Manuel 
Morales Doreste, Manuel Francisco 
Santana Del Pino, Ángelo 
Batista Arteaga, Miguel 
Miró Rodríguez, Francisco
Spinella, Giuseppe
UNESCO Clasification: 240111 Patología animal
310907 Patología
Keywords: Dog
Force platform
Osteoarthrosis, et al
Issue Date: 2013
Publisher: 0253-8318
Journal: Pakistan Veterinary Journal 
Abstract: The aim of this study was to assess the efficacy of mavacoxib, a cox-2 inhibitor, to improve the peak vertical force (PVF) and vertical impulse (VI) of lame client-owned dogs with severe coxofemoral osteoarthrosis (OA) by using a force platform. A group of ten canarian presa dogs with lameness and pain for a severe osteoarthrosis due to hip dysplasia were used for this study. Five additional sound dogs of the same breed were used as control groups. A single force platform used to register vertical forces was mounted in a 7 m runway. Mean (+/- SD) values for speed of dogs were 1.6 +/- 0.5 m/s. Data corresponding with 5 valid trials were recorded at walk at day 0, 7, 60 and 180 after starting treatment procedure. The dosing regimen consisted of a loading oral dose of 2 mg/kg to be repeated after 14 days, thereafter the dosing interval was 1 month. OA dogs showed a significant improvement of PVF after two months of about 7% bm in the force exerted by diseased limbs and a significant VI improvement after two months of about 1.6% bm in the VI exerted by diseased limbs. This study clearly showed that dogs treated with mavacoxib increased PVF over time, as soon as seven days after medical therapy, demonstrating a high potential for clinical use in the treatment of lameness associated with OA of hip joint.
ISSN: 0253-8318
Source: Pakistan Veterinary Journal [ISSN 0253-8318], v. 33 (2), p. 229-233
Appears in Collections:Artículos
Adobe PDF (220,37 kB)
Show full item record


checked on Feb 5, 2023


checked on May 9, 2021

Page view(s)

checked on Jul 23, 2022


checked on Jul 23, 2022

Google ScholarTM



Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.